Effect of Liraglutide on Epicardial Fat in Subjects With Type 2 Diabetes

Trial Profile

Effect of Liraglutide on Epicardial Fat in Subjects With Type 2 Diabetes

Completed
Phase of Trial: Phase IV

Latest Information Update: 06 Mar 2017

At a glance

  • Drugs Liraglutide (Primary) ; Metformin
  • Indications Type 2 diabetes mellitus
  • Focus Pharmacodynamics
  • Most Recent Events

    • 02 Mar 2017 Status changed from active, no longer recruiting to completed.
    • 01 Feb 2017 Status changed from recruiting to active, no longer recruiting, according to the results published in the Obesity (Silver Spring, Md.)
    • 01 Feb 2017 Primary endpoint (Echocardiographic epicardial fat thickness) has been met, according to the results published in the Obesity (Silver Spring, Md.)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top